NDC 0025-0166

Synarel

Nafarelin Acetate

Synarel is a Nasal Spray, Metered in the Human Prescription Drug category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Nafarelin Acetate.

Product ID0025-0166_34ad5a9a-caad-4431-8242-de13789731a8
NDC0025-0166
Product TypeHuman Prescription Drug
Proprietary NameSynarel
Generic NameNafarelin Acetate
Dosage FormSpray, Metered
Route of AdministrationNASAL
Marketing Start Date1990-02-13
Marketing CategoryNDA / NDA
Application NumberNDA019886
Labeler NamePfizer Laboratories Div Pfizer Inc
Substance NameNAFARELIN ACETATE
Active Ingredient Strength2 mg/mL
Pharm ClassesGonadotropin Releasing Hormone Receptor Agonist [EPC], Gonadotropin Releasing Hormone Receptor Agonists [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0025-0166-08

1 BOTTLE, SPRAY in 1 CARTON (0025-0166-08) > 8 mL in 1 BOTTLE, SPRAY
Marketing Start Date1990-02-13
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0025-0166-08 [00025016608]

Synarel SPRAY, METERED
Marketing CategoryNDA
Application NumberNDA019886
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1990-02-13

Drug Details

Active Ingredients

IngredientStrength
NAFARELIN ACETATE2 mg/mL

Pharmacological Class

  • Gonadotropin Releasing Hormone Receptor Agonists [MoA]
  • Gonadotropin Releasing Hormone Receptor Agonist [EPC]
  • Gonadotropin Releasing Hormone Receptor Agonists [MoA]
  • Gonadotropin Releasing Hormone Receptor Agonist [EPC]

Trademark Results [Synarel]

Mark Image

Registration | Serial
Company
Trademark
Application Date
SYNAREL
SYNAREL
75228431 2172477 Dead/Cancelled
G. D. Searle & Co.
1997-01-21
SYNAREL
SYNAREL
73699567 1495608 Live/Registered
SYNTEX (U.S.A.) INC.
1987-12-07

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.